Analyst Ratings for Neurocrine Bio. (NBIX)
NBIX Rating Summary
NBIX Price Target Summary
- Highest: $150.00 (Oppenheimer)
- Lowest: $101.00 (BMO Capital)
- Average: $124.84
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$124.84 (+13.3%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Avg. $ Target:
$124.84 (+13.3%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/14/2022 | Evercore ISI | Josh Schimmer | Downgrade | In Line (Outperform) |
130.00 (140.00) |
123.22 (110.22) |
-10.55% | Details |
| 10/11/2022 | UBS | Ashwani Verma | New Coverage | Buy (N/A) |
135.00 (N/A) |
106.84 (110.22) |
3.16% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
